AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 13.169
NA - Nord America 7.251
EU - Europa 2.616
SA - Sud America 1.047
AF - Africa 121
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.267
Nazione #
HK - Hong Kong 9.076
US - Stati Uniti d'America 7.097
SG - Singapore 1.799
BR - Brasile 797
CN - Cina 797
VN - Vietnam 668
IT - Italia 447
RU - Federazione Russa 412
UA - Ucraina 353
DE - Germania 329
IE - Irlanda 224
TR - Turchia 199
FR - Francia 197
KR - Corea 161
SE - Svezia 157
GB - Regno Unito 139
EE - Estonia 107
AR - Argentina 99
IN - India 98
CA - Canada 76
FI - Finlandia 74
BD - Bangladesh 69
JP - Giappone 53
EC - Ecuador 43
IQ - Iraq 41
MX - Messico 41
ID - Indonesia 35
PL - Polonia 35
ZA - Sudafrica 33
PK - Pakistan 32
AU - Australia 31
NL - Olanda 28
VE - Venezuela 27
CO - Colombia 26
NZ - Nuova Zelanda 24
ES - Italia 23
UZ - Uzbekistan 21
CZ - Repubblica Ceca 18
CL - Cile 17
PY - Paraguay 17
KE - Kenya 16
MA - Marocco 16
AT - Austria 15
SA - Arabia Saudita 12
MY - Malesia 11
TN - Tunisia 11
DZ - Algeria 10
PH - Filippine 10
AZ - Azerbaigian 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
BE - Belgio 8
ET - Etiopia 8
IL - Israele 8
JO - Giordania 8
AL - Albania 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
LB - Libano 7
LT - Lituania 7
OM - Oman 7
EG - Egitto 6
NP - Nepal 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
EU - Europa 5
KZ - Kazakistan 5
BG - Bulgaria 4
CH - Svizzera 4
GT - Guatemala 4
HR - Croazia 4
SN - Senegal 4
BH - Bahrain 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HN - Honduras 3
LY - Libia 3
ME - Montenegro 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
TH - Thailandia 3
BS - Bahamas 2
BW - Botswana 2
CY - Cipro 2
DK - Danimarca 2
IR - Iran 2
KH - Cambogia 2
LC - Santa Lucia 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
ZW - Zimbabwe 2
AM - Armenia 1
Totale 24.242
Città #
Hong Kong 9.058
Ann Arbor 1.105
Singapore 855
San Jose 792
Princeton 518
Chandler 509
Wilmington 468
Ashburn 433
Jacksonville 429
Dallas 414
Houston 255
Dublin 210
Woodbridge 201
Council Bluffs 194
Beijing 168
Izmir 166
Ho Chi Minh City 165
The Dalles 160
Lauterbourg 155
Dong Ket 136
Hanoi 130
Nanjing 112
Moscow 111
Tallinn 107
Andover 104
Boardman 86
São Paulo 72
Los Angeles 71
Salerno 69
Munich 65
Pellezzano 64
Düsseldorf 55
Norwalk 53
Dearborn 44
New York 44
Santa Clara 43
Shenyang 43
Nanchang 39
Naples 37
Tokyo 36
Fairfield 34
Mestre 34
Haiphong 31
Frankfurt am Main 29
Hebei 29
Rio de Janeiro 29
San Francisco 27
Redwood City 26
Warsaw 26
Jiaxing 25
Montreal 25
Da Nang 24
Nuremberg 23
Chennai 22
Rome 22
Changsha 21
Pune 21
Amsterdam 19
Brooklyn 19
Tashkent 19
Tianjin 18
Baghdad 17
Boston 17
Orem 17
Atlanta 16
Milan 16
Poplar 16
San Diego 16
Washington 16
Belo Horizonte 15
London 15
Nairobi 15
Ankara 14
Brasília 14
Casoria 14
Curitiba 14
Denver 14
Guarulhos 14
Porto Alegre 14
Quito 14
Stockholm 14
Biên Hòa 13
Guangzhou 13
Phoenix 13
Turku 13
Caracas 12
Guayaquil 12
Seoul 12
Auckland 11
Cape Town 11
Seattle 11
Sydney 11
Thái Bình 11
Campinas 10
Chicago 10
Columbus 10
Dhaka 10
Manchester 10
Shanghai 10
West Jordan 10
Totale 18.814
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 985
Sex Differences in Parkinson’s Disease: From Bench to Bedside 649
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 607
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 596
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 546
Gender differences in microRNA expression in levodopa-naive PD patients 543
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 524
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 504
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 429
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 421
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 394
The most effective way to obtain long-term memory is to increase first presentation duration of single words 365
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 324
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 322
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 289
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 285
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 275
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 269
Classifying Different Stages of Parkinson’s Disease Through Random Forests 259
Metabolomics in Parkinson's disease 257
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 243
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 236
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 221
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 209
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 209
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 200
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 194
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 193
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 192
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 181
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 178
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 171
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 171
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 165
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 162
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 159
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 157
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 157
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 154
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 150
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 147
Increased bilirubin levels in de novo Parkinson's disease 145
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 145
Quitting smoking: An early non-motor feature of Parkinson's disease? 142
Abnormal eating behaviors in progressive supranuclear palsy. 141
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 141
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 139
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 139
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 137
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 137
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 135
Machine learning can predict mild cognitive impairment in Parkinson's disease 134
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 131
Bisphenol A glucuronidation in patients with Parkinson's disease 131
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 130
Freezing of gait and executive functions in patients with Parkinson’s disease 126
Clinical and neurological abnormalities in adult celiac disease. 126
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 125
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 123
Gender and non motor fluctuations in Parkinson's disease: A prospective study 123
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 121
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 118
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 112
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 112
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 110
“Response to Apomorphine in early Parkinson’s disease”. 110
Cognitive correlates of “pure apathy” in Parkinson's disease 110
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 110
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 110
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 110
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 110
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 109
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 108
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 107
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 105
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 104
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 104
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 104
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 104
Uric acid relates to dopamine transporter availability in Parkinson's disease. 102
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 102
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 101
The "eye of the tiger" sign in pure akinesia with gait freezing. 100
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 100
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 99
Agreement between Optoelectronic System and Wearable Sensors for the Evaluation of Gait Spatiotemporal Parameters in Progressive Supranuclear Palsy 98
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 98
Gait patterns and cognition in Parkinson's disease 98
Parkinson’s disease and the spectrum of Lewy body disease 96
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 94
Resting brain networks in patients with Parkinson's disease and freezing of gait 94
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 93
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 92
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 92
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 92
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 89
Screening performances of an 8-item UPSIT Italian version in the diagnosis of Parkinson's disease 88
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 88
Cognitive contributions to gait and falls: Evidence and implications 88
Performing a short sway to distinguish Parkinsonisms 87
Totale 19.311
Categoria #
all - tutte 69.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.968


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 0 0 0 0 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202615.003 1.587 4.538 3.992 682 920 437 1.312 305 431 799 0 0
Totale 24.664